Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
About this item
Full title
Author / Creator
Publisher
BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BioMed Central Ltd
Subjects
More information
Alternative Titles
Full title
Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4304125
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4304125
Other Identifiers
ISSN
1710-1492,1710-1484
E-ISSN
1710-1492
DOI
10.1186/1710-1492-10-S2-A5